home > drugs a-z list > aldurazyme (laronidase) drug center

Aldurazyme

font size

Aldurazyme Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Aldurazyme Prescribing Information: Indications & Dosage

ALDURAZYME (laronidase) is indicated for patients with Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I) and for patients with the Scheie form who have moderate to severe symptoms. The risks and benefits of treating mildly affected patients with the Scheie form have not been established.

ALDURAZYME (laronidase) has been shown to improve pulmonary function and walking capacity. ALDURAZYME (laronidase) has not been evaluated for effects on the central nervous system manifestations of the disorder.

Read the complete drug monograph for Aldurazyme »

What is Patient information?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Aldurazyme Patient Information: Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Some people receiving a laronidase injection have had a reaction to the infusion (when the medicine is injected into the vein). Tell your caregiver right away if you have a headache, skin rash or itching, warmth or tingly feeling, or trouble breathing when laronidase is injected.

Less serious side effects may include:

  • runny or stuffy nose, sore throat, cough;
  • mild skin rash;
  • n...

Read the complete patient information for Aldurazyme »

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.